Walleye Trading Advisors »

Verve Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $240k 17k 13.94

More positions owned by Walleye Trading Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon Put Option (AMZN)
Tesla Motors Put Option (TSLA)
Meta Platforms Cl A Call Option (META)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Select Sector Spdr Tr Financial Call Option (XLF)
Palo Alto Networks Call Option (PANW)

View all positions for Walleye Trading Advisors

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics